Lv62
2046 积分 2023-06-19 加入
Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display
1个月前
已完结
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
2个月前
已完结
The impact of CD3 affinity-attenuation on T cell engaging bispecific antibodies: is it really that simple?
2个月前
已完结
Clonal Variant Analysis of Antibody Engineering Libraries
2个月前
已完结
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
2个月前
已完结
Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases
3个月前
已关闭
A facile yeast-display approach for antibody mask discovery
3个月前
已完结
1137 EVOLVE205, a highly potent 2:1 CD20-targeted CD2 co-stimulatory T cell engager engineered for the treatment of B cell malignancies and B cell autoimmune diseases
3个月前
已完结
Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating
3个月前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
3个月前
已完结
皖公网安备34019202002308
